Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 1154757-24-0
- Molecular formula
- C25H48N6O10
- Molecular weight
- 592.7 g/mol
- Drug class
- Aminoglycoside antibacterial agent
- Mechanism of action
- Binds to the bacterial 30S ribosomal subunit and inhibits protein synthesis, producing concentration-dependent bactericidal activity against susceptible Enterobacteriaceae.
- Indications / reported uses
- Treatment of adults with complicated urinary tract infection, including pyelonephritis, caused by designated susceptible Enterobacteriaceae when limited or no alternative treatment options are available, under the product label.
Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1243fcd3-de84-428b-901e-d83d65e4d98c · https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=0b82ffed-27f4-4f5c-8135-670c148f0e12
Identification source: PubChem record (CID 42613186). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.